Ligand Pharmaceuticals (LGND) Current Taxes (2019 - 2026)
Ligand Pharmaceuticals (LGND) reported Current Taxes of $1.9 million for Q1 2026, up 4.99% on a YoY basis from $1.8 million in Q1 2025, and up 52.78% sequentially from $1.2 million in Q4 2025.
Ligand Pharmaceuticals (LGND) Current Taxes (2019 - 2026) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 7 years of Current Taxes data on file, last reported at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes rose 4.99% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 million (up 4.99% YoY), and the FY2025 full-year result was $1.2 million, up 3.34% from the prior year.
- Current Taxes improved to $1.9 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $11.4 million in Q2 2023 to a low of $305000.0 in Q2 2025.
- A 5-year average of $3.2 million and a median of $1.8 million in 2025 frame the typical range for Current Taxes.
- Peak annual rise in Current Taxes reached 201.08% in 2023, while the deepest fall reached 87.59% in 2023.
- Tracing LGND's Current Taxes over 5 years: stood at $9.7 million in 2022, then tumbled by 87.59% to $1.2 million in 2023, then declined by 0.42% to $1.2 million in 2024, then rose by 3.34% to $1.2 million in 2025, then soared by 52.78% to $1.9 million in 2026.
- Business Quant data shows LGND's Current Taxes at $1.9 million in Q1 2026, $1.2 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | 1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Jun 30, 2025 | 305,000.00 |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 2.09 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 11.39 Mn |
| Sep 30, 2022 | 9.70 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.80 Mn |
| Sep 30, 2020 | 674,000.00 |
| Sep 30, 2019 | 16.57 Mn |
| Jun 30, 2019 | 47.46 Mn |
| Mar 31, 2019 | 114.00 Mn |